HKHisanobu Kaiya

Hisanobu Kaiya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hisanobu Kaiya has a total of 99 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Anxious‐depressive attack—A clinical state with intrusive rumination

    by Hisanobu Kaiya, Takeshi Otowa, Tsukasa Sasaki, Shota Noda, Naomi Matsuda, Yojiro Sakai, Fusaka Minami

    Aim: The present study aimed to examine anxious‐depressive attack (ADA) regarding its characteristics and the circumstances of onset, thereby clarifying why ADA has remained underrecognized. Methods: In this cross‐sectional study, 286 psychiatric outpatients were assessed using structured clinical interviews. ADA was diagnosed according to predefined criteria, characterized by sudden and recurrent episodes beginning with intense anxious‐depressive distress, followed by prolonged intrusive rumination involving negative memories or future worries and prominent negative emotions. Data on prevalence, onset, temporal patterns, phenomenology, and coping behaviors were systematically collected. Results: The lifetime prevalence of ADA was 21.7%, with onset typically during adolescence or early adulthood. Episodes most commonly occurred during periods of mental disengagement, particularly in the evening or at night, and typically lasted 2–3 h. Detailed intrusive thoughts were predominantly autobiographical, emotionally intense, and often related to temporally distant experiences. While most patients could recall the onset, offset, and content of their episodes, 43.5% regarded ADA as a mental state that anyone might experience and 29.0% had never disclosed their experiences. Maladaptive coping behaviors, including suicidal behavior or sexual derailment, were observed in 40.3% of cases. Conclusion: ADA represents a distinctive mental state preserving consciousness and memory coexist with reduced self‐reflective awareness of the pathological nature of the episode. Its ego‐syntonic, covert nature, prolonged duration, and relative lack of prominent somatic symptoms may contribute to underrecognition of ADA. Recognizing ADA in clinical practice should facilitate more accurate clinical assessment suggesting an appropriate treatment strategy.

  • Open Access

    Anxious Depressive Attack (ADA) -its prevalence and clinical implication

    by Hisanobu Kaiya, Shota Noda, Satomi Matsumoto, Yojiro Sakai, Takeshi Otowa, Tsukasa Sasaki, Fusaka Minami

    Anxious-Depressive Attack (ADA) is one of the three types of anxiety attacks originally described by Freud. ADA is characterized by the sudden onset of int


  • Open Access

    High‐intensity mindfulness and cognitive behavioral group therapy for social anxiety disorder: Preliminary efficacy

    by Shota Noda, Kentaro Shirotsuki, Yoshio Kodama, Mutsuhiro Nakao, Hisanobu Kaiya

    Aim: Cost and probability biases are known to predict improvements in symptoms of social anxiety disorder (SAD). This study developed a high‐intensity mindfulness and cognitive behavioral group therapy (M‐CBT) program—comprising mindfulness training, psychoeducation, cognitive restructuring, exposure exercises, and group sharing—designed to reduce these biases. The intervention was delivered in a group format, and its preliminary efficacy in patients with SAD was evaluated in a pilot single‐arm trial. Methods: Patients ( N = 10) diagnosed with SAD through a structured clinical interview participated in an eight‐session M‐CBT program. They completed a set of questionnaires assessing SAD symptoms, cost and probability biases, fear of negative evaluation, self‐focused attention, depressive symptoms, subjective happiness, dispositional mindfulness, cognitive reappraisal, and suppression at pre‐intervention, mid‐intervention, post‐intervention, and follow‐up. Results: Analyses using linear mixed‐effects models revealed that high‐intensity M‐CBT produced improvements in SAD symptoms, cost and probability biases, depressive symptoms, subjective happiness, dispositional mindfulness, and cognitive reappraisal ( p < 0.05). The intervention also yielded significant reductions in cost and probability biases from pre‐ to post‐treatment and at follow‐up, with large effect sizes (cost bias: Cohen's d = 0.85–1.27; probability bias: d = 1.07–2.42). In contrast, the effect sizes for SAD symptoms were moderate ( d = 0.57–0.67). Conclusions: These findings suggest that high‐intensity M‐CBT can alleviate SAD symptoms and reduce cost and probability biases. Moreover, delivering M‐CBT in a high‐intensity format appears to be effective for individuals with SAD. Future randomized‐controlled trials are warranted to more rigorously confirm these effects.

  • Open Access

    Case Report: Case report : Mindfulness training led to catharsis and mindfulness-to-meaning in a patient with social anxiety disorder comorbid with persistent depressive disorder (Dysthymia)

    by Hisanobu Kaiya, Asuka Hasegawa, Chika Komatsu, Shota Noda, Fusaka Minami, Philippe Goldin, Yosuke Hasegawa

    Background The use of mindfulness in the treatment of anxiety and depression is becoming more and more widespread, but there are few reports that it has fundamentally changed patients’ sense of life. Case Presentation This report showed 9 year’s progress of treatment for Social Anxiety Disorder and Persistent Depressive Disorder in a 41-year-old female patient experiencing a long-term painful married life with a reckless husband and controlling mother-in-law. During the past 25 months, she received 180 sessions of mindfulness training, resulting in complete remission of the anxiety and depression symptoms. After the 30th session she experienced an episode of the catharsis during the mindfulness training and experienced what can be called Mindfulness-To-Meaning, which is characterized by durable eudaimonic well-being in the face of adversity. Conclusions The psychological mechanisms that supported arriving at Mindfulness-To-Meaning are delineated as: Heightened (1) awareness which promoted (2) verbalization of the primary theme of suppression, in which the stress was (3) appraised metacognitively. Then (4) decentering permitted integrating this painful theme into a new adaptive self and world view, which resulted in (5) emotional catharsis, or release. Furthermore (6) positive appraisal of this experience enhanced awareness and led to the experience of (7) Mindfulness-To-Meaning.

  • Open Access

    Anxious‐depressive attack and rejection sensitivity—Toward a new approach to treatment‐resistant depression

    by Hisanobu Kaiya

    This paper aimed to find clues to treatment‐resistant depression (TRD) solutions. Depression comorbid with anxiety is often treatment‐resistant where anxious‐depressive attack (ADA) often lurks. ADA is a recently proposed clinical idea for just a psychological version of a panic attack. It mostly begins with an abrupt surge of intense anxiety followed by uninterrupted intrusive thoughts; lasting ruminations about regret or worry produced by violent anxiety, agitation, and loneliness. Acting‐out behaviors such as deliberate self‐injury and over‐dose may also be observed during the attack. As the basic psychopathology of ADA, rejection sensitivity (RS) was revealed by a structural equation model. It is said that the presence of RS in depressive disorders implies a poor prognosis. The following biological markers for RS were reviewed in the literature: first, the involvement of the μ‐opioid receptor function in RS and, secondly, hypersensitivity of the dopamine D4 receptor (DRD4) in the medial prefrontal cortex. The latter has been suggested in fear‐conditioned animal experiments. Manipulation of the μ‐opioid receptor function together with the DRD4 function may culminate in a treatment for RS, which could contribute to the development of a treatment for TRD via the improvement of ADA.


  • Freiburg Mindfulness Inventory‑-Short Form; Japanese Version

    by Shota Noda, Chika Komatsu, Yumi Honda, Yosuke Hasegawa, Asuka Hasegawa, Mari Higuchi, Takanobu Suzuki, Hiroaki Kumano, Itaru Fukui, Hisanobu Kaiya

  • Top Cited Papers

    World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders

    by Borwin Bandelow, Christer Allgulander, David S. Baldwin, Daniel Lucas da Conceição Costa, Damiaan Denys, Nesrin Dilbaz, Katharina Domschke, Elias Eriksson, Naomi A. Fineberg, Josef Hättenschwiler, et al.

    This is the third version of the guideline of the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive–Compulsive and Po...


  • World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part II: OCD and PTSD

    by Borwin Bandelow, Christer Allgulander, David S. Baldwin, Daniel Lucas da Conceição Costa, Damiaan Denys, Nesrin Dilbaz, Katharina Domschke, Eric Hollander, Siegfried Kasper, Hans-Jürgen Möller, et al.

    Aim: This is the third version of the guideline of the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive–Compulsive and Posttraumatic Stress Disorders which was published in 2002 and revised in 2008. Method: A consensus panel of 34 international experts representing 22 countries developed recommendations based on efficacy and acceptability of the treatments. In this version, not only medications but also psychotherapies and other non-pharmacological interventions were evaluated, applying the same rigorous methods that are standard for the assessment of medication treatments. Result: The present paper (Part II) contains recommendations based on published randomised controlled trials (RCTs) for the treatment of OCD (n = 291) and PTSD (n = 234) in children, adolescents, and adults. The accompanying paper (Part I) contains the recommendations for the treatment of anxiety disorders. For OCD, first-line treatments are selective serotonin reuptake inhibitors (SSRIs) and cognitive behavioural therapy (CBT). Internet-CBT was also superior to active controls. Several second-line medications are available, including clomipramine. For treatment-resistant cases, several options are available, including augmentation of SSRI treatment with antipsychotics and other drugs. Other non-pharmacological treatments, including repetitive transcranial magnetic stimulation (rTMS), deep brain stimulation (DBS) and others were also evaluated. For PTSD, SSRIs and the SNRI venlafaxine are first-line treatments. CBT is the psychotherapy modality with the best body of evidence. For treatment-unresponsive patients, augmentation of SSRI treatment with antipsychotics may be an option. Conclusion: OCD and PTSD can be effectively treated with CBT and medications.


  • Open Access

    Mindfulness Training led to Catharsis and Mindfulness-To-Meaning in a Patient with Social Anxiety Disorder Comorbid with Persistent Depressive Disorder (Dysthymia) - A Case Report with Patient's Personal Note -

    by Hisanobu Kaiya, Asuka Hasegawa, Chika Komatsu, Shota Noda, Fusaka Minami, Philippe Goldin, Yosuke Hasegawa

    Background:The use of mindfulness in the treatment of anxiety and depression is becoming more and more widespread, but there are few reports that it has fundamentally changed patients' sense of life. Case Presentation:This report showed 9 year’s progress of treatment for Social Anxiety Disorder and Persistent Depressive Disorder in a 41year-old female patient experiencing a long-term painful married life with a carefree husband and controlling mother-in-law. During the past 25 months, she received 180 sessions of mindfulness training, resulting in complete remission of the anxiety and depression symptoms. After the 30th session she experienced an episode of the catharsis during the mindfulness training and experienced what can be called Mindfulness-To-Meaning, which is characterized by durable eudaimonic well-being in the face of adversity. Discussion and Conclutions:The psychological mechanisms that supported arriving at Mindfulness-To-Meaning were delineated as: Heightened (1) awareness which promoted (2) verbalization of the primary theme of suppression, in which the stress was (3) appraised metacognitively. Then (4) decentering permitted integrating this painful theme into a new adaptive self and world view, which resulted in (5) emotional catharsis, or release. Furthermore (6) positive appraisal of this experience enhanced awareness and led to the experience of (7) Mindfulness-To-Meaning .

  • Open Access

    The anxious-depressive attack severity scale: development and initial validation and reliability

    by Shota Noda, Satomi Matsumoto, Naoko Kawasaki, Mina Masaki, Itaru Fukui, Hisanobu Kaiya

    Background: Anxious-depressive attack (ADA) is a symptom complex that comprises sudden intense feelings of anxiety or depression, intrusive rumination of regretful memories or future worries, emotional distress due to painful thoughts, and coping behaviors to manage emotional distress. ADA has been observed trans-diagnostically across various psychiatric disorders. Although the importance of ADA treatment has been indicated, a scale to measure the severity of ADA has not been developed. This study aimed to develop an Anxious-Depressive Attack Severity Scale (ADAS) to measure the severity of ADA symptoms and examine its reliability and validity. Methods: A total of 242 outpatients responded to a questionnaire and participated in an interview, which were designed to measure the severity of ADA, depressive, anxiety, anxious depression, and social anxiety symptoms. Based on the diagnostic criteria for ADA, 54 patients were confirmed to have ADA and were included in the main study analyses. Results: The exploratory factor analysis of the ADAS identified a two factor structure: severity of ADA symptoms and ADA frequency and coping behaviors. McDonald’s ωt coefficients were high for the overall scale and the first factor (ωt = .78 and ωt = .83, respectively) but low for the second factor (ωt = .49). The ADAS score was significantly positively correlated with clinical symptoms related to anxiety and depression. Conclusion: The present study demonstrated that the ADAS has sufficient reliability and validity; however, internal consistency was insufficient for the second factor. Overall, the ADAS has potential to be a valuable tool for use in clinical trials of ADA.